Status:

COMPLETED

Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis

Lead Sponsor:

Travanti Pharma Inc.

Collaborating Sponsors:

ResearchPoint

Conditions:

Lateral Epicondylitis

(Tennis Elbow)

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The objective of this study is to determine the safety and efficacy of a dexamethasone iontophoretic transdermal patch for the treatment of pain associated with lateral epicondylitis (tennis elbow).

Detailed Description

Detailed Description: This trial is a randomized, double-blind, placebo-controlled, parallel-group trial in subjects diagnosed with lateral epicondylitis (tennis elbow). Subjects entered into the tri...

Eligibility Criteria

Inclusion

  • Subjects with onset of lateral epicondylitis symptoms no more than 12 weeks prior to study entry
  • Female patients of childbearing potential must agree to use a medically accepted form of birth control.

Exclusion

  • Subjects with other medical conditions/injuries of the elbow that would account for pain in the area
  • Subjects who would require continuation of current pain medications during treatment
  • Must not have received a prior corticosteroid injection for lateral epicondylitis in the affected arm

Key Trial Info

Start Date :

October 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2009

Estimated Enrollment :

216 Patients enrolled

Trial Details

Trial ID

NCT00794976

Start Date

October 1 2008

End Date

May 1 2009

Last Update

May 13 2015

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Birmingham, Alabama, United States

2

Phoenix, Arizona, United States

3

Tucson, Arizona, United States

4

San Diego, California, United States

Dexamethasone Iontophoretic Patch for the Treatment of Pain Associated With Lateral Epicondylitis | DecenTrialz